| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 184 | 5.340 | 3.172 | 0 |
| Total Income - EUR | - | - | - | - | - | 0 | 47.153 | 53.307 | 6.356 | 0 |
| Total Expenses - EUR | - | - | - | - | - | 50 | 45.436 | 77.091 | 19.628 | 3.037 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -50 | 1.717 | -23.784 | -13.271 | -3.037 |
| Net Profit/Loss - EUR | - | - | - | - | - | -50 | 1.715 | -23.838 | -13.299 | -3.037 |
| Employees | - | - | - | - | - | 0 | 3 | 4 | 1 | 0 |
Check the financial reports for the company - Novusmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 10.529 | 10.442 | 8.855 | 5.838 |
| Current Assets | - | - | - | - | - | 198 | 48.847 | 3.139 | 69 | 41 |
| Inventories | - | - | - | - | - | 0 | 2.662 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 1.671 | 0 | 0 |
| Cash | - | - | - | - | - | 198 | 46.185 | 1.468 | 69 | 41 |
| Shareholders Funds | - | - | - | - | - | -9 | 1.707 | -22.126 | -35.358 | -38.198 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 207 | 12.125 | 35.707 | 44.282 | 44.077 |
| Income in Advance | - | - | - | - | - | 0 | 45.544 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8695 - 8695" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Novusmed S.r.l.